Bird, Fish, and Fly Cells Reprogrammed

Using mouse genes, researchers partially transform differentiated, non-mammalian cells into pluripotent stem cells.

Written byKerry Grens
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

COURTESY RICARDO ROSSELLOThe ability to reprogram differentiated cells toward pluripotency has been a remarkable achievement, though its application has mostly been limited to mammals. Researchers published in eLife this week (September 3) evidence of induced pluripotency in cells from the non-mammalian model organisms zebra finch, chicken, zebrafish, and Drosophila. While the study’s authors cautioned that these cells were only partially reprogrammed, and therefore not induced pluripotent stem cells (iPSCs), lead author Ricardo Rossello said that “they have a slew of phenotypic characteristics of stem cells.”

The University of Puerto Rico’s Rossello and his colleagues, who study vocalization in songbirds, had been looking for a way to gather stem cells from the animals. “But nobody has really quite isolated stem cells” from the zebra finch, he said. So they decided to try and create them. In humans and other mammals, the overexpression of four genes can turn a skin or some other specialized cell into a pluripotent stem cell.

Although homology to these genes was not great in the finch, Rossello said a portion of the genes’ proteins involved in transcriptional regulation, the DNA binding domains, were quite similar. So they went ahead and inserted a viral vector carrying the four mouse reprogramming factors into embryonic fibroblast cells from the songbird. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform